2023. Comparing The Effect Of The SGLT-2 Inhibitors And DPP-4 Inhibitor Combined Therapy With Sulphonylureas And Metformin Combined Therapy In Patients With Type 2 Diabetic Nephropathy. Journal of Pharmaceutical Negative Results. (Jul. 2023), 498–502. DOI:https://doi.org/10.47750/pnr.2023.14.04.59.